Tuttle RM - Search Results

1

Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.

Ghossein RA, Leboeuf R, Patel KN, Rivera M, Katabi N, Carlson DL, Tallini G, Shaha A, Singh B, Tuttle RM. Ghossein RA, et al. Among authors: tuttle rm. Thyroid. 2007 Jul;17(7):655-61. doi: 10.1089/thy.2007.0061. Thyroid. 2007. PMID: 17696836

2

The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults.

Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL. Fenton C, et al. Among authors: tuttle rm. Thyroid. 2000 Apr;10(4):349-57. doi: 10.1089/thy.2000.10.349. Thyroid. 2000. PMID: 10807064

3

Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma.

Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A, Drucker WD. Robbins RJ, et al. Among authors: tuttle rm. J Clin Endocrinol Metab. 2001 Feb;86(2):619-25. doi: 10.1210/jcem.86.2.7189. J Clin Endocrinol Metab. 2001. PMID: 11158019

4

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin.

Robbins RJ, Tuttle RM, Sonenberg M, Shaha A, Sharaf R, Robbins H, Fleisher M, Larson SM. Robbins RJ, et al. Among authors: tuttle rm. Thyroid. 2001 Sep;11(9):865-9. doi: 10.1089/105072501316973127. Thyroid. 2001. PMID: 11575856

5

Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.

Wang W, Larson SM, Tuttle RM, Kalaigian H, Kolbert K, Sonenberg M, Robbins RJ. Wang W, et al. Among authors: tuttle rm. Thyroid. 2001 Dec;11(12):1169-75. doi: 10.1089/10507250152741028. Thyroid. 2001. PMID: 12186505

6

A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.

Robbins RJ, Larson SM, Sinha N, Shaha A, Divgi C, Pentlow KS, Ghossein R, Tuttle RM. Robbins RJ, et al. Among authors: tuttle rm. J Nucl Med. 2002 Nov;43(11):1482-8. J Nucl Med. 2002. PMID: 12411552 Free article.

7

Genome-wide appraisal of thyroid cancer progression.

Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. Wreesmann VB, et al. Among authors: tuttle rm. Am J Pathol. 2002 Nov;161(5):1549-56. doi: 10.1016/S0002-9440(10)64433-1. Am J Pathol. 2002. PMID: 12414503 Free PMC article.

8

Postoperative management of differentiated thyroid cancer.

Cohen EG, Tuttle RM, Kraus DH. Cohen EG, et al. Among authors: tuttle rm. Otolaryngol Clin North Am. 2003 Feb;36(1):129-57. doi: 10.1016/s0030-6665(02)00137-8. Otolaryngol Clin North Am. 2003. PMID: 12803014 Review.

9

Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.

Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. Wreesmann VB, et al. Among authors: tuttle rm. Genes Chromosomes Cancer. 2004 Aug;40(4):355-64. doi: 10.1002/gcc.20049. Genes Chromosomes Cancer. 2004. PMID: 15188460

10

Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.

Robbins RJ, Srivastava S, Shaha A, Ghossein R, Larson SM, Fleisher M, Tuttle RM. Robbins RJ, et al. Among authors: tuttle rm. J Clin Endocrinol Metab. 2004 Dec;89(12):6010-6. doi: 10.1210/jc.2003-031573. J Clin Endocrinol Metab. 2004. PMID: 15579752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters